Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use

NCT ID: NCT00799669

Last Updated: 2018-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

370 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-12-05

Study Completion Date

2020-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: A counseling program that motivates patients to stop smoking and drinking may reduce the risk of oral cancer. It is not yet known whether motivational stop smoking counseling or motivational stop-smoking and stop drinking counseling is more effective in helping patients stop smoking and drinking.

PURPOSE: This randomized clinical trial is studying how well treatment to stop smoking and drinking works in preventing oral cancer in smokers in Puerto Rico.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

* To evaluate the effects of a motivational and problem-solving smoking cessation (MAPS) and a motivational and problem solving approach on at-risk alcohol use and smoking cessation (MAPS+) among Puerto Rican at-risk drinkers/smokers who call the Puerto Rico Quitline (PRQ).
* To assess effects of MAPS and MAPS+ on treatment mechanisms and the role of those mechanisms in mediating these effects on at-risk drinking and smoking cessation.
* To evaluate the cost-effectiveness of MAPS and MAPS+ in the reduction of at-risk drinking and smoking cessation.

OUTLINE: Minimization randomization is applied using the following variables: age, gender, cigarettes/day, number of drinks/day, and depression (score on the Center of Epidemiologic Studies Depression Scale). Patients are randomized to 1 of 2 intervention arms.

* Arm I (MAPS): Patients receive culturally sensitive self-help materials tailored for alcohol and tobacco users and 7 telephone counseling calls. The MAPS approach includes motivational interviewing and cognitive behavioral/problem-solving that focus on smoking cessation.
* Arm II (MAPS+): Patients receive culturally sensitive self-help materials tailored for alcohol and tobacco users and 7 telephone counseling calls. The MAPS+ approach includes motivational interviewing and cognitive behavioral/problems solving that focus on smoking cessation and the reduction of at-risk alcohol use.

In both arms, patients receive counseling calls over 15-30 minutes the week before quit date (QD), on QD, 3-5 days after QD, 7-10 days after QD, 15-30 days after QD, 45-60 days after QD, and on day 90 after QD. Patients complete questionnaires for alcohol- and smoking-related measures, self efficacy, stress/negative affects/depression, social support, and physical activity at baseline and weeks 12, 26 and 52 after QD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Head and Neck Cancer Tobacco Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MAPS+

MAPS+ (Motivation and Problem-Solving Plus):

Counseling using specific treatment approach that focuses on combined smoking cessation and the reduction of at-risk alcohol use.

smoking cessation intervention

Intervention Type BEHAVIORAL

Standard quit-smoking counseling to help decrease their risk of cancer.

counseling intervention

Intervention Type OTHER

Counseling focusing on decreasing risk of getting cancer by decreasing smoking and alcohol use.

preventive intervention

Intervention Type OTHER

questionnaire administration

Intervention Type OTHER

MAPS

MAPS (Motivation and Problem-Solving):

Counseling treatment approach with a focus on smoking cessation.

smoking cessation intervention

Intervention Type BEHAVIORAL

Standard quit-smoking counseling to help decrease their risk of cancer.

questionnaire administration

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

smoking cessation intervention

Standard quit-smoking counseling to help decrease their risk of cancer.

Intervention Type BEHAVIORAL

counseling intervention

Counseling focusing on decreasing risk of getting cancer by decreasing smoking and alcohol use.

Intervention Type OTHER

preventive intervention

Intervention Type OTHER

questionnaire administration

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

survey

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

DISEASE CHARACTERISTICS:

* Current daily smoker
* Called the Puerto Rico Quitline
* Motivated to quit smoking in the next 30 days
* Exhibits at least one of the following criteria for at-risk drinking:

* An average of ≥ 2 alcoholic beverages/day for men or ≥ 1 drink/day for women in the past 30 days
* Two or more occasions of consuming ≥ 5 alcoholic beverages/day for men or ≥ 4 drinks/day for women in the past 30 days
* Driving after consuming ≥ 3 drinks in the past 30 days
* Score of ≤ 15 on the Alcohol Use Disorders Identification Test

PATIENT CHARACTERISTICS:

* Not pregnant
* Residing in Puerto Rico
* Not currently incarcerated or in jail
* No other household member enrolled in this study
* Viable telephone number and home address
* Willing to provide the names, addresses, and phone numbers of up to 3 collaterals

PRIOR CONCURRENT THERAPY:

* Not specified
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Wetter, PhD, MS, BA

Role: STUDY_CHAIR

M.D. Anderson Cancer Center

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

University of Texas MD Anderson Cancer Center Official Website

http://www.cancer.gov/about-cancer/treatment/clinical-trials/search?

National Cancer Institute (NCI) Central Website for Cancer Research

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MDA-2005-0791

Identifier Type: -

Identifier Source: secondary_id

CDR0000626365

Identifier Type: OTHER

Identifier Source: secondary_id

U54CA096300

Identifier Type: NIH

Identifier Source: secondary_id

View Link

U54CA096297

Identifier Type: NIH

Identifier Source: secondary_id

View Link

NCI-2012-02110

Identifier Type: REGISTRY

Identifier Source: secondary_id

CDR0000626365

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Alcohol Counseling for Telephone Quitline Callers
NCT01120080 COMPLETED PHASE1/PHASE2
Alcohol Cessation Among Head and Neck Cancer Survivors
NCT05570851 ENROLLING_BY_INVITATION NA
Effective Ads for Quitting Smoking
NCT06485479 COMPLETED NA